Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2015

01-05-2015 | Review

Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease

Authors: Brice Malgras, Karine Pautrat, Xavier Dray, Pierre Pasquier, Patrice Valleur, Marc Pocard, Philippe Soyer

Published in: Digestive Diseases and Sciences | Issue 5/2015

Login to get access

Abstract

Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have been used more frequently during the last 25 years, there is no significant decrease in the need for surgery in patients with CD. Unfortunately, surgery is not curative, as the disease ultimately reoccurs in a substantial subset of patients. To best identify the patients who will require a specific treatment and to plane the most appropriate therapeutic approach, it is important to precisely define the type, the size, and the location of CD stenosis. Diagnostic approaches aim to distinguish fibrotic from inflammatory strictures. Medical therapy is required for inflammatory stenosis. Mechanical treatments are required when fibrotic CD strictures are symptomatic. The choice between endoscopic balloon dilation, stricturoplasty, and laparoscopic or open surgery is based on the presence of perforating complications, the remaining length of small bowel, and the number and length of strictures. The non-hierarchical decision-making process for the treatment of fibrotic CD therefore requires multidisciplinary clinical rounds with radiologists, gastroenterologists, interventional endoscopists, and surgeons.
Literature
1.
go back to reference Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429.PubMed Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429.PubMed
2.
go back to reference Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated by strictures: a systematic review. Gut. 2013;62:1072–1084.PubMed Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated by strictures: a systematic review. Gut. 2013;62:1072–1084.PubMed
3.
go back to reference Malgras B, Soyer P, Boudiaf M, et al. Accuracy of imaging for predicting operative approach in Crohn’s disease. Br J Surg. 2012;99:1011–1020.PubMed Malgras B, Soyer P, Boudiaf M, et al. Accuracy of imaging for predicting operative approach in Crohn’s disease. Br J Surg. 2012;99:1011–1020.PubMed
4.
go back to reference Wibmer AG, Kroesen AJ, Gröne J, Buhr HJ, Ritz JP. Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease–review of the literature. Int J Colorectal Dis. 2010;25:1149–1157.PubMed Wibmer AG, Kroesen AJ, Gröne J, Buhr HJ, Ritz JP. Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease–review of the literature. Int J Colorectal Dis. 2010;25:1149–1157.PubMed
5.
go back to reference Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis. 2010;4:63–101.PubMed Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis. 2010;4:63–101.PubMed
6.
go back to reference De’ Angelis N, Carra MC, Borrelli O, et al. Short- and long-term efficacy of endoscopic balloon dilation in Crohn’s disease strictures. World J Gastroenterol. 2013;19:2660–2667. De’ Angelis N, Carra MC, Borrelli O, et al. Short- and long-term efficacy of endoscopic balloon dilation in Crohn’s disease strictures. World J Gastroenterol. 2013;19:2660–2667.
7.
go back to reference Fornasa F, Benassuti C, Benazzato L. Role of magnetic resonance enterography in differentiating between fibrotic and active inflammatory small bowel stenosis in patients with crohn’s disease. J Clin Imaging Sci. 2011;1:35.PubMedCentralPubMed Fornasa F, Benassuti C, Benazzato L. Role of magnetic resonance enterography in differentiating between fibrotic and active inflammatory small bowel stenosis in patients with crohn’s disease. J Clin Imaging Sci. 2011;1:35.PubMedCentralPubMed
8.
go back to reference Hassan C, Zullo A, De Francesco V, et al. Systematic review: endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther. 2007;26:1457–1464.PubMed Hassan C, Zullo A, De Francesco V, et al. Systematic review: endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther. 2007;26:1457–1464.PubMed
9.
go back to reference Solberg IC, Vatn MH, Høie O, et al. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–1438.PubMed Solberg IC, Vatn MH, Høie O, et al. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–1438.PubMed
10.
go back to reference Soyer P, Boudiaf M, Sirol M, et al. Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis. Radiology. 2010;254:755–764.PubMed Soyer P, Boudiaf M, Sirol M, et al. Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis. Radiology. 2010;254:755–764.PubMed
11.
go back to reference Regan MC, Flavin BM, Fitzpatrick JM, O’Connell PR. Stricture formation in Crohn’s disease: the role of intestinal fibroblasts. Ann Surg. 2000;231:46–50.PubMedCentralPubMed Regan MC, Flavin BM, Fitzpatrick JM, O’Connell PR. Stricture formation in Crohn’s disease: the role of intestinal fibroblasts. Ann Surg. 2000;231:46–50.PubMedCentralPubMed
12.
go back to reference Limketkai BN, Bayless TM. Editorial: can stenosis in ileal Crohn’s disease be prevented by current therapy? Am J Gastroenterol. 2013;108:1755–1756.PubMed Limketkai BN, Bayless TM. Editorial: can stenosis in ileal Crohn’s disease be prevented by current therapy? Am J Gastroenterol. 2013;108:1755–1756.PubMed
13.
go back to reference Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science. Curr Opin Gastroenterol. 2008;24:462–468.PubMed Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science. Curr Opin Gastroenterol. 2008;24:462–468.PubMed
14.
go back to reference Johnson LA, Rodansky ES, Sauder KL, et al. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts. Inflamm Bowel Dis. 2013;19:891–903.PubMedCentralPubMed Johnson LA, Rodansky ES, Sauder KL, et al. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts. Inflamm Bowel Dis. 2013;19:891–903.PubMedCentralPubMed
15.
go back to reference Wells RG. The role of matrix stiffness in regulating cell behavior. Hepatol Baltim Md. 2008;47:1394–1400. Wells RG. The role of matrix stiffness in regulating cell behavior. Hepatol Baltim Md. 2008;47:1394–1400.
16.
go back to reference Otte J-M, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology. 2003;124:1866–1878.PubMed Otte J-M, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology. 2003;124:1866–1878.PubMed
17.
go back to reference Graham MF. Pathogenesis of intestinal strictures in Crohn’s disease-an update. Inflamm Bowel Dis. 1995;1:220–227.PubMed Graham MF. Pathogenesis of intestinal strictures in Crohn’s disease-an update. Inflamm Bowel Dis. 1995;1:220–227.PubMed
18.
go back to reference Coelho J, Soyer P, Pautrat K, et al. Management of ileal stenosis in patients with Crohn’s disease. Gastroenterol Clin Biol. 2009;33:F75–F81.PubMed Coelho J, Soyer P, Pautrat K, et al. Management of ileal stenosis in patients with Crohn’s disease. Gastroenterol Clin Biol. 2009;33:F75–F81.PubMed
19.
go back to reference Maglinte DD. Small bowel imaging—a rapidly changing field and a challenge to radiology. Eur Radiol. 2006;16:967–971.PubMed Maglinte DD. Small bowel imaging—a rapidly changing field and a challenge to radiology. Eur Radiol. 2006;16:967–971.PubMed
20.
go back to reference Soyer P, Boudiaf M, Fishman EK, et al. Imaging of malignant neoplasms of the mesenteric small bowel: new trends and perspectives. Crit Rev Oncol Hematol. 2011;80:10–30.PubMed Soyer P, Boudiaf M, Fishman EK, et al. Imaging of malignant neoplasms of the mesenteric small bowel: new trends and perspectives. Crit Rev Oncol Hematol. 2011;80:10–30.PubMed
21.
go back to reference Maglinte DD, Sandrasegaran K, Chiorean M, Dewitt J, McHenry L, Lappas JC. Radiologic investigations complement and add diagnostic information to capsule endoscopy of small-bowel diseases Am J Roentgenol. 2007;189:306–312. Maglinte DD, Sandrasegaran K, Chiorean M, Dewitt J, McHenry L, Lappas JC. Radiologic investigations complement and add diagnostic information to capsule endoscopy of small-bowel diseases Am J Roentgenol. 2007;189:306–312.
22.
go back to reference Khalife S, Soyer P, Alatawi A, et al. Obscure gastrointestinal bleeding: preliminary comparison of 64-section CT enteroclysis with video capsule endoscopy. Eur Radiol. 2011;21:79–86.PubMed Khalife S, Soyer P, Alatawi A, et al. Obscure gastrointestinal bleeding: preliminary comparison of 64-section CT enteroclysis with video capsule endoscopy. Eur Radiol. 2011;21:79–86.PubMed
23.
go back to reference Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn’s disease. Eur Radiol. 2008;18:438–447.PubMed Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn’s disease. Eur Radiol. 2008;18:438–447.PubMed
24.
go back to reference Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology. 2006;238:517–530.PubMed Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology. 2006;238:517–530.PubMed
25.
go back to reference Ebinger M, Rieber A, Leidl R. Cost-effectiveness of magnetic resonance imaging and enteroclysis in the diagnostic imaging of Crohn’s disease. Int J Technol Assess Health Care. 2002;18:711–717.PubMed Ebinger M, Rieber A, Leidl R. Cost-effectiveness of magnetic resonance imaging and enteroclysis in the diagnostic imaging of Crohn’s disease. Int J Technol Assess Health Care. 2002;18:711–717.PubMed
26.
27.
go back to reference Voderholzer WA, Beinhoelzl J, Rogalla P, et al. Small bowel involvement in Crohn’s disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut. 2005;54:369–373.PubMedCentralPubMed Voderholzer WA, Beinhoelzl J, Rogalla P, et al. Small bowel involvement in Crohn’s disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut. 2005;54:369–373.PubMedCentralPubMed
28.
go back to reference Turetschek K, Schober E, Wunderbaldinger P, et al. Findings at helical CT-enteroclysis in symptomatic patients with crohn disease: correlation with endoscopic and surgical findings. J Comput Assist Tomogr. 2002;26:488–492.PubMed Turetschek K, Schober E, Wunderbaldinger P, et al. Findings at helical CT-enteroclysis in symptomatic patients with crohn disease: correlation with endoscopic and surgical findings. J Comput Assist Tomogr. 2002;26:488–492.PubMed
29.
go back to reference Vogel J, da Luz Moreira A, Baker M, et al. CT enterography for Crohn’s disease: accurate preoperative diagnostic imaging. Dis Colon Rectum. 2007;50:1761–1769. Vogel J, da Luz Moreira A, Baker M, et al. CT enterography for Crohn’s disease: accurate preoperative diagnostic imaging. Dis Colon Rectum. 2007;50:1761–1769.
30.
go back to reference Maglinte DD, Bender GN, Heitkamp DE, Lappas JC, Kelvin FM. Multidetector-row helical CT enteroclysis. Radiol Clin North Am. 2003;41:249–262.PubMed Maglinte DD, Bender GN, Heitkamp DE, Lappas JC, Kelvin FM. Multidetector-row helical CT enteroclysis. Radiol Clin North Am. 2003;41:249–262.PubMed
31.
go back to reference Boudiaf M, Soyer P, Terem C, Pelage JP, Maissiat E, Rymer R. Ct evaluation of small bowel obstruction. Radiographics. 2001;21:613–624.PubMed Boudiaf M, Soyer P, Terem C, Pelage JP, Maissiat E, Rymer R. Ct evaluation of small bowel obstruction. Radiographics. 2001;21:613–624.PubMed
32.
go back to reference Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inflamm Bowel Dis. 2011;17:1073–1080.PubMed Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inflamm Bowel Dis. 2011;17:1073–1080.PubMed
33.
go back to reference Pilleul F, Godefroy C, Yzebe-Beziat D, Dugougeat-Pilleul F, Lachaux A, Valette PJ. Magnetic resonance imaging in Crohn’s disease. Gastroenterol Clin Biol. 2005;29:803–808.PubMed Pilleul F, Godefroy C, Yzebe-Beziat D, Dugougeat-Pilleul F, Lachaux A, Valette PJ. Magnetic resonance imaging in Crohn’s disease. Gastroenterol Clin Biol. 2005;29:803–808.PubMed
34.
go back to reference Rodriguez P, Mendez R, Matute F, Hernandez P, Mendoza JL. Imaging Crohn disease: mR enterography. J Comput Assist Tomogr. 2014;38:219–227.PubMed Rodriguez P, Mendez R, Matute F, Hernandez P, Mendoza JL. Imaging Crohn disease: mR enterography. J Comput Assist Tomogr. 2014;38:219–227.PubMed
35.
go back to reference Negaard A, Paulsen V, Sandvik L, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn’s disease, the oral contrast method and MR enteroclysis. Eur Radiol. 2007;17:2294–2301.PubMed Negaard A, Paulsen V, Sandvik L, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn’s disease, the oral contrast method and MR enteroclysis. Eur Radiol. 2007;17:2294–2301.PubMed
36.
go back to reference Pariente B, Peyrin-Biroulet L, Cohen L, Zagdanski AM, Colombel JF. Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn disease. Am J Roentgenol. 2011;197:42–49. Pariente B, Peyrin-Biroulet L, Cohen L, Zagdanski AM, Colombel JF. Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn disease. Am J Roentgenol. 2011;197:42–49.
37.
go back to reference Brenner DJ, Hall EJ. Computed tomography–an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–2284.PubMed Brenner DJ, Hall EJ. Computed tomography–an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–2284.PubMed
38.
go back to reference Lenze F, Wessling J, Bremer J, et al. Detection and differentiation of inflammatory versus fibromatous Crohn’s disease strictures: prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation. Inflamm Bowel Dis. 2012;18:2252–2260.PubMed Lenze F, Wessling J, Bremer J, et al. Detection and differentiation of inflammatory versus fibromatous Crohn’s disease strictures: prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation. Inflamm Bowel Dis. 2012;18:2252–2260.PubMed
39.
go back to reference Bickelhaupt S, Froehlich JM, Cattin R, et al. Differentiation between active and chronic Crohn’s disease using MRI small-bowel motility examinations—initial experience. Clin Radiol. 2013;68:1247–1253.PubMed Bickelhaupt S, Froehlich JM, Cattin R, et al. Differentiation between active and chronic Crohn’s disease using MRI small-bowel motility examinations—initial experience. Clin Radiol. 2013;68:1247–1253.PubMed
40.
go back to reference Maccioni F, Patak MA, Signore A, Laghi A. New frontiers of MRI in Crohn’s disease: motility imaging, diffusion-weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI). Abdom Imaging. 2012;37:974–982.PubMed Maccioni F, Patak MA, Signore A, Laghi A. New frontiers of MRI in Crohn’s disease: motility imaging, diffusion-weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI). Abdom Imaging. 2012;37:974–982.PubMed
41.
go back to reference Froehlich JM, Waldherr C, Stoupis C, Erturk SM, Patak MA. MR motility imaging in Crohn’s disease improves lesion detection compared with standard MR imaging. Eur Radiol. 2010;20:1945–1951.PubMed Froehlich JM, Waldherr C, Stoupis C, Erturk SM, Patak MA. MR motility imaging in Crohn’s disease improves lesion detection compared with standard MR imaging. Eur Radiol. 2010;20:1945–1951.PubMed
42.
go back to reference Cullmann JL, Bickelhaupt S, Froehlich JM, et al. MR imaging in Crohn’s disease: correlation of MR motility measurement with histopathology in the terminal ileum. Neurogastroenterol Motil. 2013;25:749-e577.PubMed Cullmann JL, Bickelhaupt S, Froehlich JM, et al. MR imaging in Crohn’s disease: correlation of MR motility measurement with histopathology in the terminal ileum. Neurogastroenterol Motil. 2013;25:749-e577.PubMed
43.
go back to reference Zappa M, Stefanescu C, Cazals-Hatem D, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis. 2011;17:984–993.PubMed Zappa M, Stefanescu C, Cazals-Hatem D, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis. 2011;17:984–993.PubMed
44.
go back to reference Chiorean MV, Sandrasegaran K, Saxena R, Maglinte DD, Nakeeb A, Johnson CS. Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterol. 2007;102:2541–2550.PubMed Chiorean MV, Sandrasegaran K, Saxena R, Maglinte DD, Nakeeb A, Johnson CS. Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterol. 2007;102:2541–2550.PubMed
45.
go back to reference Adler J, Punglia DR, Dillman JR, et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn’s disease. Inflamm Bowel Dis. 2012;18:849–856.PubMed Adler J, Punglia DR, Dillman JR, et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn’s disease. Inflamm Bowel Dis. 2012;18:849–856.PubMed
46.
go back to reference Holtmann MH, Neurath MF. Anti-TNF strategies in stenosing and fistulizing Crohn’s disease. Int J Colorectal Dis. 2005;20:1–8.PubMed Holtmann MH, Neurath MF. Anti-TNF strategies in stenosing and fistulizing Crohn’s disease. Int J Colorectal Dis. 2005;20:1–8.PubMed
47.
go back to reference Samimi R, Flasar MH, Kavic S, Tracy K, Cross RK. Outcome of medical treatment of stricturing and penetrating Crohn’s disease: a retrospective study. Inflamm Bowel Dis. 2010;16:1187–1194.PubMed Samimi R, Flasar MH, Kavic S, Tracy K, Cross RK. Outcome of medical treatment of stricturing and penetrating Crohn’s disease: a retrospective study. Inflamm Bowel Dis. 2010;16:1187–1194.PubMed
48.
go back to reference Sorrentino D. Role of biologics and other therapies in stricturing Crohn’s disease: what have we learnt so far? Digestion. 2008;77:38–47.PubMed Sorrentino D. Role of biologics and other therapies in stricturing Crohn’s disease: what have we learnt so far? Digestion. 2008;77:38–47.PubMed
49.
go back to reference Sailer J, Peloschek P, Reinisch W, Vogelsang H, Turetschek K, Schima W. Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol. 2008;18:2512–2521.PubMed Sailer J, Peloschek P, Reinisch W, Vogelsang H, Turetschek K, Schima W. Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol. 2008;18:2512–2521.PubMed
50.
go back to reference Keuchel M. Double balloon (push-and-pull) enteroscopy: breakthrough in the management of small intestinal strictures in Crohn’s disease? Eur J Gastroenterol Hepatol. 2007;19:523–525.PubMed Keuchel M. Double balloon (push-and-pull) enteroscopy: breakthrough in the management of small intestinal strictures in Crohn’s disease? Eur J Gastroenterol Hepatol. 2007;19:523–525.PubMed
51.
go back to reference Yamamoto H, Kita H. Double-balloon endoscopy. Curr Opin Gastroenterol. 2005;21:573–577.PubMed Yamamoto H, Kita H. Double-balloon endoscopy. Curr Opin Gastroenterol. 2005;21:573–577.PubMed
52.
go back to reference Tharian B, Caddy G, Tham TC. Enteroscopy in small bowel Crohn’s disease: a review. World J Gastrointest Endosc. 2013;5:476–486.PubMedCentralPubMed Tharian B, Caddy G, Tham TC. Enteroscopy in small bowel Crohn’s disease: a review. World J Gastrointest Endosc. 2013;5:476–486.PubMedCentralPubMed
53.
go back to reference Caunedo-Alvarez A, Romero-Vazquez J, Herrerias-Gutierrez J-M. Patency and Agile capsules. World J Gastroenterol. 2008;14:5269–5273.PubMedCentralPubMed Caunedo-Alvarez A, Romero-Vazquez J, Herrerias-Gutierrez J-M. Patency and Agile capsules. World J Gastroenterol. 2008;14:5269–5273.PubMedCentralPubMed
54.
go back to reference Bourreille A, Ignjatovic A, Aabakken L, et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy. 2009;41:618–637.PubMed Bourreille A, Ignjatovic A, Aabakken L, et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy. 2009;41:618–637.PubMed
55.
go back to reference Wiarda BM, Mensink PBF, Heine DGN, et al. Small bowel Crohn’s disease: mR enteroclysis and capsule endoscopy compared to balloon-assisted enteroscopy. Abdom Imaging. 2012;37:397–403.PubMedCentralPubMed Wiarda BM, Mensink PBF, Heine DGN, et al. Small bowel Crohn’s disease: mR enteroclysis and capsule endoscopy compared to balloon-assisted enteroscopy. Abdom Imaging. 2012;37:397–403.PubMedCentralPubMed
56.
go back to reference Soyer P. Obscure gastrointestinal bleeding: difficulties in comparing CT enterography and video capsule endoscopy. Eur Radiol. 2012;22:1167–1171.PubMed Soyer P. Obscure gastrointestinal bleeding: difficulties in comparing CT enterography and video capsule endoscopy. Eur Radiol. 2012;22:1167–1171.PubMed
57.
go back to reference D’Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn’s disease. Gastroenterology. 1997;112:1475–1481.PubMed D’Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn’s disease. Gastroenterology. 1997;112:1475–1481.PubMed
58.
go back to reference Schoepfer AM, Beglinger C, Straumann A, et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn’s disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol. 2010;105:162–169.PubMed Schoepfer AM, Beglinger C, Straumann A, et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn’s disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol. 2010;105:162–169.PubMed
59.
go back to reference Papay P, Ignjatovic A, Karmiris K, et al. Optimising monitoring in the management of Crohn’s disease: a physician’s perspective. J Crohns Colitis. 2013;7:653–669.PubMed Papay P, Ignjatovic A, Karmiris K, et al. Optimising monitoring in the management of Crohn’s disease: a physician’s perspective. J Crohns Colitis. 2013;7:653–669.PubMed
60.
go back to reference Reinisch W, Wang Y, Oddens BJ, Link R. C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn’s disease: a post hoc analysis from ACCENT I. Aliment Pharmacol Ther. 2012;35:568–576.PubMed Reinisch W, Wang Y, Oddens BJ, Link R. C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn’s disease: a post hoc analysis from ACCENT I. Aliment Pharmacol Ther. 2012;35:568–576.PubMed
61.
go back to reference Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:524–534.PubMed Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:524–534.PubMed
62.
go back to reference Gisbert JP, McNicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis. 2009;41:56–66.PubMed Gisbert JP, McNicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis. 2009;41:56–66.PubMed
63.
go back to reference Sipponen T, Kärkkäinen P, Savilahti E, et al. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings. Aliment Pharmacol Ther. 2008;28:1221–1229.PubMed Sipponen T, Kärkkäinen P, Savilahti E, et al. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings. Aliment Pharmacol Ther. 2008;28:1221–1229.PubMed
64.
go back to reference Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut. 2005;54:237–241.PubMedCentralPubMed Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut. 2005;54:237–241.PubMedCentralPubMed
65.
go back to reference Lichtenstein GR, Olson A, Travers S, et al. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn’s disease. Am J Gastroenterol. 2006;101:1030–1038.PubMed Lichtenstein GR, Olson A, Travers S, et al. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn’s disease. Am J Gastroenterol. 2006;101:1030–1038.PubMed
66.
go back to reference Tay GS, Binion DG, Eastwood D, et al. Multivariate analysis suggests improved perioperative outcome in Crohn’s disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery. 2003;134:565–572.PubMed Tay GS, Binion DG, Eastwood D, et al. Multivariate analysis suggests improved perioperative outcome in Crohn’s disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery. 2003;134:565–572.PubMed
67.
go back to reference Riello L, Talbotec C, Garnier-Lengliné H, et al. Tolerance and efficacy of azathioprine in pediatric Crohn’s disease. Inflamm Bowel Dis. 2011;17:2138–2143.PubMed Riello L, Talbotec C, Garnier-Lengliné H, et al. Tolerance and efficacy of azathioprine in pediatric Crohn’s disease. Inflamm Bowel Dis. 2011;17:2138–2143.PubMed
68.
go back to reference Peyrin-Biroulet L, Oussalah A, Williet N, et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn’s disease. Gut. 2011;60:930–936.PubMed Peyrin-Biroulet L, Oussalah A, Williet N, et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn’s disease. Gut. 2011;60:930–936.PubMed
69.
go back to reference Lichtenstein GR, Abreu MT, Cohen R, et al. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006;130:940–987.PubMed Lichtenstein GR, Abreu MT, Cohen R, et al. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006;130:940–987.PubMed
70.
go back to reference Louis E, Boverie J, Dewit O, et al. Treatment of small bowel subocclusive Crohn’s disease with infliximab: an open pilot study. Acta Gastro Enterol Belg. 2007;70:15–19. Louis E, Boverie J, Dewit O, et al. Treatment of small bowel subocclusive Crohn’s disease with infliximab: an open pilot study. Acta Gastro Enterol Belg. 2007;70:15–19.
71.
go back to reference Pelletier A-L, Kalisazan B, Wienckiewicz J, et al. Infliximab treatment for symptomatic Crohn’s disease strictures. Aliment Pharmacol Ther. 2009;29:279–285.PubMed Pelletier A-L, Kalisazan B, Wienckiewicz J, et al. Infliximab treatment for symptomatic Crohn’s disease strictures. Aliment Pharmacol Ther. 2009;29:279–285.PubMed
72.
go back to reference Holtmann M, Wanitschke R, Helisch A, et al. Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn’s disease. Z Gastroenterol. 2003;41:11–17.PubMed Holtmann M, Wanitschke R, Helisch A, et al. Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn’s disease. Z Gastroenterol. 2003;41:11–17.PubMed
73.
go back to reference Pallotta N, Barberani F, Hassan N-A, et al. Effect of infliximab on small bowel stenoses in patients with Crohn’s disease. World J Gastroenterol. 2008;14:1885–1890.PubMedCentralPubMed Pallotta N, Barberani F, Hassan N-A, et al. Effect of infliximab on small bowel stenoses in patients with Crohn’s disease. World J Gastroenterol. 2008;14:1885–1890.PubMedCentralPubMed
74.
go back to reference Fidder H, Schnitzler F, Ferrante M, et al. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut. 2009;58:501–508.PubMed Fidder H, Schnitzler F, Ferrante M, et al. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut. 2009;58:501–508.PubMed
75.
go back to reference Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn’s disease: TREAT registry. Clin Gastroenterol Hepatol. 2006;4:621–630.PubMed Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn’s disease: TREAT registry. Clin Gastroenterol Hepatol. 2006;4:621–630.PubMed
76.
go back to reference Bodger K, Kikuchi T, Hughes D. Cost-effectiveness of biological therapy for Crohn’s disease: markov cohort analyses incorporating United Kingdom patient-level cost data. Aliment Pharmacol Ther. 2009;30:265–274.PubMed Bodger K, Kikuchi T, Hughes D. Cost-effectiveness of biological therapy for Crohn’s disease: markov cohort analyses incorporating United Kingdom patient-level cost data. Aliment Pharmacol Ther. 2009;30:265–274.PubMed
77.
go back to reference Sorrentino D, Avellini C, Beltrami CA, et al. Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn’s disease. Int J Colorectal Dis. 2006;21:276–281.PubMed Sorrentino D, Avellini C, Beltrami CA, et al. Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn’s disease. Int J Colorectal Dis. 2006;21:276–281.PubMed
78.
go back to reference Sorrentino D, Terrosu G, Vadalà S, et al. Fibrotic strictures and anti-TNF-alpha therapy in Crohn’s disease. Digestion. 2007;75:22–24.PubMed Sorrentino D, Terrosu G, Vadalà S, et al. Fibrotic strictures and anti-TNF-alpha therapy in Crohn’s disease. Digestion. 2007;75:22–24.PubMed
79.
go back to reference Knapp AB, Mirsky FJ, Dillon EH, et al. Successful infliximab therapy for a duodenal stricture caused by Crohn’s disease. Inflamm Bowel Dis. 2005;11:1123–1125.PubMed Knapp AB, Mirsky FJ, Dillon EH, et al. Successful infliximab therapy for a duodenal stricture caused by Crohn’s disease. Inflamm Bowel Dis. 2005;11:1123–1125.PubMed
80.
go back to reference Sorrentino D, Terrosu G, Avellini C, et al. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med. 2007;167:1804–1807.PubMed Sorrentino D, Terrosu G, Avellini C, et al. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med. 2007;167:1804–1807.PubMed
81.
go back to reference Rubin DT, Uluscu O, Sederman R. Response to biologic therapy in Crohn’s disease is improved with early treatment: an analysis of health claims data. Inflamm Bowel Dis. 2012;18:2225–2231.PubMed Rubin DT, Uluscu O, Sederman R. Response to biologic therapy in Crohn’s disease is improved with early treatment: an analysis of health claims data. Inflamm Bowel Dis. 2012;18:2225–2231.PubMed
82.
go back to reference Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis. 2010;4:28–62.PubMed Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis. 2010;4:28–62.PubMed
83.
go back to reference Wallaert JB, De Martino RR, Marsicovetere PS, et al. Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis Colon Rectum. 2012;55:1138–1144.PubMedCentralPubMed Wallaert JB, De Martino RR, Marsicovetere PS, et al. Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis Colon Rectum. 2012;55:1138–1144.PubMedCentralPubMed
84.
go back to reference Cao Y, Gao F, Liao C, et al. Meta-analysis of medical treatment and placebo treatment for preventing postoperative recurrence in Crohn’s disease (CD). Int J Colorectal Dis. 2009;24:509–520.PubMed Cao Y, Gao F, Liao C, et al. Meta-analysis of medical treatment and placebo treatment for preventing postoperative recurrence in Crohn’s disease (CD). Int J Colorectal Dis. 2009;24:509–520.PubMed
85.
go back to reference Reese GE, Nanidis T, Borysiewicz C, et al. The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. Int J Colorectal Dis. 2008;23:1213–1221.PubMed Reese GE, Nanidis T, Borysiewicz C, et al. The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. Int J Colorectal Dis. 2008;23:1213–1221.PubMed
86.
go back to reference Gustavsson A, Magnuson A, Blomberg B, et al. Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn’s disease. Aliment Pharmacol Ther. 2013;37:430–437.PubMed Gustavsson A, Magnuson A, Blomberg B, et al. Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn’s disease. Aliment Pharmacol Ther. 2013;37:430–437.PubMed
87.
go back to reference Scimeca D, Mocciaro F, Cottone M, et al. Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn’s disease strictures. Dig Liver Dis. 2011;43:121–125.PubMed Scimeca D, Mocciaro F, Cottone M, et al. Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn’s disease strictures. Dig Liver Dis. 2011;43:121–125.PubMed
88.
go back to reference Thomas-Gibson S, Brooker JC, Hayward CMM, et al. Colonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol. 2003;15:485–488.PubMed Thomas-Gibson S, Brooker JC, Hayward CMM, et al. Colonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol. 2003;15:485–488.PubMed
89.
go back to reference Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn’s disease. Gastroenterology. 2006;130:650–656.PubMed Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn’s disease. Gastroenterology. 2006;130:650–656.PubMed
90.
go back to reference Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–250.PubMed Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–250.PubMed
91.
go back to reference Hagel AF, Hahn A, Dauth W, et al. Outcome and complications of endoscopic balloon dilatations in various types of ileocaecal and colonic stenosis in patients with Crohn’s disease. Surg Endosc. 2014;10:2966–2972. Hagel AF, Hahn A, Dauth W, et al. Outcome and complications of endoscopic balloon dilatations in various types of ileocaecal and colonic stenosis in patients with Crohn’s disease. Surg Endosc. 2014;10:2966–2972.
92.
go back to reference Mueller T, Rieder B, Bechtner G, et al. The response of Crohn’s strictures to endoscopic balloon dilation. Aliment Pharmacol Ther. 2010;31:634–639.PubMed Mueller T, Rieder B, Bechtner G, et al. The response of Crohn’s strictures to endoscopic balloon dilation. Aliment Pharmacol Ther. 2010;31:634–639.PubMed
93.
go back to reference East JE, Brooker JC, Rutter MD, et al. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn’s strictures. Clin Gastroenterol Hepatol. 2007;5:1065–1069.PubMed East JE, Brooker JC, Rutter MD, et al. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn’s strictures. Clin Gastroenterol Hepatol. 2007;5:1065–1069.PubMed
94.
go back to reference Di Nardo G, Oliva S, Passariello M, et al. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn’s disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointest Endosc. 2010;72:1201–1208.PubMed Di Nardo G, Oliva S, Passariello M, et al. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn’s disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointest Endosc. 2010;72:1201–1208.PubMed
95.
go back to reference Thienpont C, D’Hoore A, Vermeire S, et al. Long-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapy. Gut. 2010;59:320–324.PubMed Thienpont C, D’Hoore A, Vermeire S, et al. Long-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapy. Gut. 2010;59:320–324.PubMed
96.
go back to reference Atreja A, Aggarwal A, Dwivedi S, et al. Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn’s disease strictures. J Crohns Colitis. 2014;8:392–400.PubMed Atreja A, Aggarwal A, Dwivedi S, et al. Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn’s disease strictures. J Crohns Colitis. 2014;8:392–400.PubMed
97.
go back to reference Gustavsson A, Magnuson A, Blomberg B, et al. Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn’s disease. Aliment Pharmacol Ther. 2012;36:151–158.PubMed Gustavsson A, Magnuson A, Blomberg B, et al. Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn’s disease. Aliment Pharmacol Ther. 2012;36:151–158.PubMed
98.
go back to reference Endo K, Takahashi S, Shiga H, et al. Short and long-term outcomes of endoscopic balloon dilatation for Crohn’s disease strictures. World J Gastroenterol. 2013;19:86–91.PubMedCentralPubMed Endo K, Takahashi S, Shiga H, et al. Short and long-term outcomes of endoscopic balloon dilatation for Crohn’s disease strictures. World J Gastroenterol. 2013;19:86–91.PubMedCentralPubMed
99.
go back to reference Raedler A, Peters I, Schreiber S. Treatment with azathioprine and budesonide prevents reoccurence of ileocolonic stenoses after endoscopic dilatation in Crohn’s disease. Gastroenterology 1997;A:1067. Raedler A, Peters I, Schreiber S. Treatment with azathioprine and budesonide prevents reoccurence of ileocolonic stenoses after endoscopic dilatation in Crohn’s disease. Gastroenterology 1997;A:1067.
100.
go back to reference Ferlitsch A, Reinisch W, Püspök A, et al. Safety and efficacy of endoscopic balloon dilation for treatment of Crohn’s disease strictures. Endoscopy. 2006;38:483–487.PubMed Ferlitsch A, Reinisch W, Püspök A, et al. Safety and efficacy of endoscopic balloon dilation for treatment of Crohn’s disease strictures. Endoscopy. 2006;38:483–487.PubMed
101.
go back to reference Honzawa Y, Nakase H, Matsuura M, et al. Prior use of immunomodulatory drugs improves the clinical outcome of endoscopic balloon dilation for intestinal stricture in patients with Crohn’s disease. Dig Endosc. 2013;25:535–543.PubMed Honzawa Y, Nakase H, Matsuura M, et al. Prior use of immunomodulatory drugs improves the clinical outcome of endoscopic balloon dilation for intestinal stricture in patients with Crohn’s disease. Dig Endosc. 2013;25:535–543.PubMed
102.
go back to reference Ono Y, Hirai F, Matsui T, et al. Value of concomitant endoscopic balloon dilation for intestinal stricture during long-term infliximab therapy in patients with Crohn’s disease. Dig Endosc. 2012;24:432–438.PubMed Ono Y, Hirai F, Matsui T, et al. Value of concomitant endoscopic balloon dilation for intestinal stricture during long-term infliximab therapy in patients with Crohn’s disease. Dig Endosc. 2012;24:432–438.PubMed
103.
go back to reference Sabaté J-M, Villarejo J, Bouhnik Y, et al. Hydrostatic balloon dilatation of Crohn’s strictures. Aliment Pharmacol Ther. 2003;18:409–413.PubMed Sabaté J-M, Villarejo J, Bouhnik Y, et al. Hydrostatic balloon dilatation of Crohn’s strictures. Aliment Pharmacol Ther. 2003;18:409–413.PubMed
104.
go back to reference Griffiths AM. Enteral nutrition in the management of Crohn’s disease. J Parenter Enteral Nutr. 2005;29:S108–S112. Griffiths AM. Enteral nutrition in the management of Crohn’s disease. J Parenter Enteral Nutr. 2005;29:S108–S112.
105.
go back to reference Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum. 2000;43:1141–1145.PubMed Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum. 2000;43:1141–1145.PubMed
106.
go back to reference Iesalnieks I, Kilger A, Glass H, et al. Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome. Int J Colorectal Dis. 2008;23:1167–1174.PubMed Iesalnieks I, Kilger A, Glass H, et al. Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome. Int J Colorectal Dis. 2008;23:1167–1174.PubMed
107.
go back to reference Froehlich F, Juillerat P, Pittet V, et al. Maintenance of surgically induced remission of Crohn’s disease. Digestion. 2007;76:130–135.PubMed Froehlich F, Juillerat P, Pittet V, et al. Maintenance of surgically induced remission of Crohn’s disease. Digestion. 2007;76:130–135.PubMed
108.
go back to reference Couckuyt H, Gevers AM, Coremans G, et al. Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective longterm analysis. Gut. 1995;36:577–580.PubMedCentralPubMed Couckuyt H, Gevers AM, Coremans G, et al. Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective longterm analysis. Gut. 1995;36:577–580.PubMedCentralPubMed
109.
go back to reference Hoffmann JC, Heller F, Faiss S, et al. Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness. Int J Colorectal Dis. 2008;23:689–696.PubMed Hoffmann JC, Heller F, Faiss S, et al. Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness. Int J Colorectal Dis. 2008;23:689–696.PubMed
110.
go back to reference Brochard C, Siproudhis L, Wallenhorst T, et al. Anorectal stricture in 102 patients with Crohn’s disease: natural history in the era of biologics. Aliment Pharmacol Ther. 2014;40:796–803.PubMed Brochard C, Siproudhis L, Wallenhorst T, et al. Anorectal stricture in 102 patients with Crohn’s disease: natural history in the era of biologics. Aliment Pharmacol Ther. 2014;40:796–803.PubMed
111.
go back to reference Linares L, Moreira LF, Andrews H, et al. Natural history and treatment of anorectal strictures complicating Crohn’s disease. Br J Surg. 1988;75:653–655.PubMed Linares L, Moreira LF, Andrews H, et al. Natural history and treatment of anorectal strictures complicating Crohn’s disease. Br J Surg. 1988;75:653–655.PubMed
112.
go back to reference Lewis RT, Maron DJ. Anorectal Crohn’s disease. Surg Clin North Am. 2010;90:83–97.PubMed Lewis RT, Maron DJ. Anorectal Crohn’s disease. Surg Clin North Am. 2010;90:83–97.PubMed
113.
go back to reference Galandiuk S, Kimberling J, Al-Mishlab TG, et al. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg. 2005;241:796–801.PubMedCentralPubMed Galandiuk S, Kimberling J, Al-Mishlab TG, et al. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg. 2005;241:796–801.PubMedCentralPubMed
114.
go back to reference Bouguen G, Siproudhis L, Bretagne J-F, et al. Nonfistulizing perianal Crohn’s disease: clinical features, epidemiology, and treatment. Inflamm Bowel Dis. 2010;16:1431–1442.PubMed Bouguen G, Siproudhis L, Bretagne J-F, et al. Nonfistulizing perianal Crohn’s disease: clinical features, epidemiology, and treatment. Inflamm Bowel Dis. 2010;16:1431–1442.PubMed
115.
go back to reference Erkelens GW, van Deventer SJH. Endoscopic treatment of strictures in Crohn’s disease. Best Pract Res Clin Gastroenterol. 2004;18:201–207.PubMed Erkelens GW, van Deventer SJH. Endoscopic treatment of strictures in Crohn’s disease. Best Pract Res Clin Gastroenterol. 2004;18:201–207.PubMed
116.
go back to reference Geiger TM, Miedema BW, Tsereteli Z, et al. Stent placement for benign colonic stenosis: case report, review of the literature, and animal pilot data. Int J Colorectal Dis. 2008;23:1007–1012.PubMed Geiger TM, Miedema BW, Tsereteli Z, et al. Stent placement for benign colonic stenosis: case report, review of the literature, and animal pilot data. Int J Colorectal Dis. 2008;23:1007–1012.PubMed
117.
go back to reference Thomas T, Abrams KR, Subramanian V, et al. Esophageal stents for benign refractory strictures: a meta-analysis. Endoscopy. 2011;43:386–393.PubMed Thomas T, Abrams KR, Subramanian V, et al. Esophageal stents for benign refractory strictures: a meta-analysis. Endoscopy. 2011;43:386–393.PubMed
118.
go back to reference Attar A, Maunoury V, Vahedi K, et al. Safety and efficacy of extractible self-expandable metal stents in the treatment of Crohn’s disease intestinal strictures: a prospective pilot study. Inflamm Bowel Dis. 2012;18:1849–1854.PubMed Attar A, Maunoury V, Vahedi K, et al. Safety and efficacy of extractible self-expandable metal stents in the treatment of Crohn’s disease intestinal strictures: a prospective pilot study. Inflamm Bowel Dis. 2012;18:1849–1854.PubMed
119.
go back to reference Branche J, Attar A, Vernier-Massouille G, et al. Extractible self-expandable metal stent in the treatment of Crohn’s disease anastomotic strictures. Endoscopy. 2012;44:E325–E326.PubMed Branche J, Attar A, Vernier-Massouille G, et al. Extractible self-expandable metal stent in the treatment of Crohn’s disease anastomotic strictures. Endoscopy. 2012;44:E325–E326.PubMed
120.
go back to reference Fazio VW, Marchetti F, Church M, et al. Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg. 1996;224:563–571. Fazio VW, Marchetti F, Church M, et al. Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg. 1996;224:563–571.
121.
go back to reference Heuman R, Boeryd B, Bolin T, et al. The influence of disease at the margin of resection on the outcome of Crohn’s disease. Br J Surg. 1983;70:519–521.PubMed Heuman R, Boeryd B, Bolin T, et al. The influence of disease at the margin of resection on the outcome of Crohn’s disease. Br J Surg. 1983;70:519–521.PubMed
122.
go back to reference McLeod RS, Wolff BG, Ross S, et al. Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum. 2009;52:919–927.PubMed McLeod RS, Wolff BG, Ross S, et al. Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum. 2009;52:919–927.PubMed
123.
go back to reference Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665–672.PubMedCentralPubMed Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665–672.PubMedCentralPubMed
124.
go back to reference Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–963.PubMed Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–963.PubMed
125.
go back to reference Sampietro GM, Cristaldi M, Porretta T, et al. Early perioperative results and surgical recurrence after strictureplasty and miniresection for complicated Crohn’s disease. Dig Surg. 2000;17:261–267.PubMed Sampietro GM, Cristaldi M, Porretta T, et al. Early perioperative results and surgical recurrence after strictureplasty and miniresection for complicated Crohn’s disease. Dig Surg. 2000;17:261–267.PubMed
126.
go back to reference Shore G, Gonzalez QH, Bondora A, et al. Laparoscopic vs conventional ileocolectomy for primary Crohn disease. Arch Surg. 2003;138:76–79.PubMed Shore G, Gonzalez QH, Bondora A, et al. Laparoscopic vs conventional ileocolectomy for primary Crohn disease. Arch Surg. 2003;138:76–79.PubMed
127.
go back to reference Simillis C, Purkayastha S, Yamamoto T, et al. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum. 2007;50:1674–1687.PubMed Simillis C, Purkayastha S, Yamamoto T, et al. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum. 2007;50:1674–1687.PubMed
128.
go back to reference Scarpa M, Angriman I, Barollo M, et al. Role of stapled and hand-sewn anastomoses in recurrence of Crohn’s disease. Hepatogastroenterology. 2004;51:1053–1057.PubMed Scarpa M, Angriman I, Barollo M, et al. Role of stapled and hand-sewn anastomoses in recurrence of Crohn’s disease. Hepatogastroenterology. 2004;51:1053–1057.PubMed
129.
go back to reference Tilney HS, Constantinides VA, Heriot AG, et al. Comparison of laparoscopic and open ileocecal resection for Crohn’s disease: a metaanalysis. Surg Endosc. 2006;20:1036–1044.PubMed Tilney HS, Constantinides VA, Heriot AG, et al. Comparison of laparoscopic and open ileocecal resection for Crohn’s disease: a metaanalysis. Surg Endosc. 2006;20:1036–1044.PubMed
130.
go back to reference Lesperance K, Martin MJ, Lehmann R, et al. National trends and outcomes for the surgical therapy of ileocolonic Crohn’s disease: a population-based analysis of laparoscopic vs. open approaches. J Gastrointest Surg. 2009;13:1251–1259.PubMed Lesperance K, Martin MJ, Lehmann R, et al. National trends and outcomes for the surgical therapy of ileocolonic Crohn’s disease: a population-based analysis of laparoscopic vs. open approaches. J Gastrointest Surg. 2009;13:1251–1259.PubMed
131.
go back to reference Milsom JW, Hammerhofer KA, Böhm B, et al. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn’s disease. Dis Colon Rectum. 2001;44:1–8.PubMed Milsom JW, Hammerhofer KA, Böhm B, et al. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn’s disease. Dis Colon Rectum. 2001;44:1–8.PubMed
132.
go back to reference Maartense S, Dunker MS, Slors JFM, et al. Laparoscopic-assisted versus open ileocolic resection for Crohn’s disease: a randomized trial. Ann Surg. 2006;243:143–149.PubMedCentralPubMed Maartense S, Dunker MS, Slors JFM, et al. Laparoscopic-assisted versus open ileocolic resection for Crohn’s disease: a randomized trial. Ann Surg. 2006;243:143–149.PubMedCentralPubMed
133.
go back to reference Shaffer VO, Wexner SD. Surgical management of Crohn’s disease. Langenbecks Arch Surg. 2013;398:13–27.PubMed Shaffer VO, Wexner SD. Surgical management of Crohn’s disease. Langenbecks Arch Surg. 2013;398:13–27.PubMed
134.
go back to reference Futami K, Arima S. Role of strictureplasty in surgical treatment of Crohn’s disease. J Gastroenterol. 2005;40:35–39.PubMed Futami K, Arima S. Role of strictureplasty in surgical treatment of Crohn’s disease. J Gastroenterol. 2005;40:35–39.PubMed
135.
go back to reference Broering DC, Eisenberger CF, Koch A, et al. Strictureplasty for large bowel stenosis in Crohn’s disease: quality of life after surgical therapy. Int J Colorectal Dis. 2001;16:81–87.PubMed Broering DC, Eisenberger CF, Koch A, et al. Strictureplasty for large bowel stenosis in Crohn’s disease: quality of life after surgical therapy. Int J Colorectal Dis. 2001;16:81–87.PubMed
136.
go back to reference Dietz DW, Laureti S, Strong SA, et al. Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg. 2001;192:330–337.PubMed Dietz DW, Laureti S, Strong SA, et al. Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg. 2001;192:330–337.PubMed
137.
go back to reference Von Roon AC, Reese G, Teare J, et al. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–855. Von Roon AC, Reese G, Teare J, et al. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–855.
138.
go back to reference Campbell L, Ambe R, Weaver J, et al. Comparison of conventional and nonconventional strictureplasties in Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum. 2012;55:714–726.PubMed Campbell L, Ambe R, Weaver J, et al. Comparison of conventional and nonconventional strictureplasties in Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum. 2012;55:714–726.PubMed
139.
go back to reference Fearnhead NS, Chowdhury R, Box B, et al. Long-term follow-up of strictureplasty for Crohn’s disease. Br J Surg. 2006;93:475–482.PubMed Fearnhead NS, Chowdhury R, Box B, et al. Long-term follow-up of strictureplasty for Crohn’s disease. Br J Surg. 2006;93:475–482.PubMed
140.
go back to reference Reese GE, Purkayastha S, Tilney HS, et al. Strictureplasty vs resection in small bowel Crohn’s disease: an evaluation of short-term outcomes and recurrence. Colorectal Dis. 2007;9:686–694.PubMed Reese GE, Purkayastha S, Tilney HS, et al. Strictureplasty vs resection in small bowel Crohn’s disease: an evaluation of short-term outcomes and recurrence. Colorectal Dis. 2007;9:686–694.PubMed
141.
go back to reference Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum. 2007;50:1968–1986.PubMed Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum. 2007;50:1968–1986.PubMed
142.
go back to reference Michelassi F, Upadhyay GA. Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn’s disease. J Surg Res. 2004;117:71–78.PubMed Michelassi F, Upadhyay GA. Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn’s disease. J Surg Res. 2004;117:71–78.PubMed
143.
go back to reference Sampietro GM, Sartani A, Danelli P, et al. Strictureplasty in the surgical treatment of complicated Crohn’s disease. Ann Ital Chir. 2003;74:659–663.PubMed Sampietro GM, Sartani A, Danelli P, et al. Strictureplasty in the surgical treatment of complicated Crohn’s disease. Ann Ital Chir. 2003;74:659–663.PubMed
144.
go back to reference Tonelli F, Fedi M, Paroli GM, et al. Indications and results of side-to-side isoperistaltic strictureplasty in Crohn’s disease. Dis Colon Rectum. 2004;47:494–501.PubMed Tonelli F, Fedi M, Paroli GM, et al. Indications and results of side-to-side isoperistaltic strictureplasty in Crohn’s disease. Dis Colon Rectum. 2004;47:494–501.PubMed
145.
go back to reference Shatari T, Clark MA, Yamamoto T, et al. Long strictureplasty is as safe and effective as short strictureplasty in small-bowel Crohn’s disease. Colorectal Dis. 2004;6:438–441.PubMed Shatari T, Clark MA, Yamamoto T, et al. Long strictureplasty is as safe and effective as short strictureplasty in small-bowel Crohn’s disease. Colorectal Dis. 2004;6:438–441.PubMed
146.
go back to reference Poggioli G, Laureti S, Pierangeli F, et al. A new model of strictureplasty for multiple and long stenoses in Crohn’s ileitis: side-to-side diseased to disease-free anastomosis. Dis Colon Rectum. 2003;46:127–130.PubMed Poggioli G, Laureti S, Pierangeli F, et al. A new model of strictureplasty for multiple and long stenoses in Crohn’s ileitis: side-to-side diseased to disease-free anastomosis. Dis Colon Rectum. 2003;46:127–130.PubMed
147.
go back to reference Tichansky D, Cagir B, Yoo E, et al. Strictureplasty for Crohn’s disease: meta-analysis. Dis Colon Rectum. 2000;43:911–919.PubMed Tichansky D, Cagir B, Yoo E, et al. Strictureplasty for Crohn’s disease: meta-analysis. Dis Colon Rectum. 2000;43:911–919.PubMed
148.
go back to reference Ambe R, Campbell L, Cagir B. A comprehensive review of strictureplasty techniques in Crohn’s disease: types, indications, comparisons, and safety. J Gastrointest Surg. 2012;16:209–217.PubMed Ambe R, Campbell L, Cagir B. A comprehensive review of strictureplasty techniques in Crohn’s disease: types, indications, comparisons, and safety. J Gastrointest Surg. 2012;16:209–217.PubMed
149.
go back to reference Yaffe BH, Korelitz BI. Prognosis for nonoperative management of small-bowel obstruction in Crohn’s disease. J Clin Gastroenterol. 1983;5:211–215.PubMed Yaffe BH, Korelitz BI. Prognosis for nonoperative management of small-bowel obstruction in Crohn’s disease. J Clin Gastroenterol. 1983;5:211–215.PubMed
150.
go back to reference Oberhuber G, Stangl PC, Vogelsang H, et al. Significant association of strictures and internal fistula formation in Crohn’s disease. Virchows Arch Int J Pathol. 2000;437:293–297. Oberhuber G, Stangl PC, Vogelsang H, et al. Significant association of strictures and internal fistula formation in Crohn’s disease. Virchows Arch Int J Pathol. 2000;437:293–297.
151.
go back to reference Miehsler W, Reinisch W, Kazemi-Shirazi L, et al. Infliximab: lack of efficacy on perforating complications in Crohn’s disease. Inflamm Bowel Dis. 2004;10:36–40.PubMed Miehsler W, Reinisch W, Kazemi-Shirazi L, et al. Infliximab: lack of efficacy on perforating complications in Crohn’s disease. Inflamm Bowel Dis. 2004;10:36–40.PubMed
152.
go back to reference Sachar DB. Ten common errors in the management of inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:205–209.PubMed Sachar DB. Ten common errors in the management of inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:205–209.PubMed
153.
go back to reference Ng SC, Kamm MA. Fulminant Crohn’s colitis: when only an antibody will do. Inflamm Bowel Dis. 2007;13:971–974.PubMed Ng SC, Kamm MA. Fulminant Crohn’s colitis: when only an antibody will do. Inflamm Bowel Dis. 2007;13:971–974.PubMed
154.
go back to reference Clark M, Colombel J-F, Feagan BC, et al. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21–23, 2006. Gastroenterology. 2007;133:312–339.PubMed Clark M, Colombel J-F, Feagan BC, et al. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21–23, 2006. Gastroenterology. 2007;133:312–339.PubMed
155.
157.
go back to reference Travis SPL, Stange EF, Lémann M, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut. 2006;55:i16–i35.PubMedCentralPubMed Travis SPL, Stange EF, Lémann M, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut. 2006;55:i16–i35.PubMedCentralPubMed
Metadata
Title
Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease
Authors
Brice Malgras
Karine Pautrat
Xavier Dray
Pierre Pasquier
Patrice Valleur
Marc Pocard
Philippe Soyer
Publication date
01-05-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3421-y

Other articles of this Issue 5/2015

Digestive Diseases and Sciences 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.